Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients

Publication date

2016-11-01

Authors

Swartz, Justin E.
Pothen, Ajit J
Wegner, Inge
Smid, Ernst JORCID 0000-0001-9652-0657ISNI 0000000394814621
Swart, Karin M A
de Bree, RemcoORCID 0000-0001-7128-5814ISNI 0000000387040744
Leenen, L. P.H.ORCID 0000-0001-8385-1801ISNI 0000000390070047
Grolman, WilkoISNI 0000000393198708

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

Objectives Patients with head and neck cancer (HNC) have a higher risk of malnutrition and sarcopenia, which is associated with adverse clinical outcome. As abdominal CT-imaging is often used to detect sarcopenia, such scans are rarely available in HNC patients, possibly explaining why no studies investigate the effect of sarcopenia in this population. We correlated skeletal muscle mass assessed on head and neck CT-scans with abdominal CT-imaging. Methods Head and neck, and abdominal CT-scans of trauma (n = 51) and HNC-patients (n = 52) were retrospectively analyzed. On the head and neck CT-scans, the paravertebral and sternocleidomastoid muscles were delineated. On the abdominal CT-scans, all muscles were delineated. Cross-sectional area (CSA) of the muscles at the level of the C3 vertebra was compared to CSA at the L3 level using linear regression. A multivariate linear regression model was established. Results HNC-patients had significantly lower muscle CSA than trauma patients (37.9 vs. 45.1 cm2, p 

Keywords

Computed tomography, Computer-assisted image analysis, Head and neck neoplasms, Lean body mass, Sarcopenia, Taverne, Oral Surgery, Oncology, Cancer Research, Journal Article

Citation

Swartz, J E, Pothen, A J, Wegner, I, Smid, E J, Swart, K M A, de Bree, R, Leenen, L P H & Grolman, W 2016, 'Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients', Oral Oncology, vol. 62, pp. 28-33. https://doi.org/10.1016/j.oraloncology.2016.09.006